Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy
CLINICAL COLORECTAL CANCER（2024）
关键词
Bevacizumab,Cost of drugs,Metastatic colorectal cancer,Third-line,Trifluridine/tipiracil
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要